ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 57 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 2.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 509,023 | $7,706,608 | 60.04% |
| MPM ASSET MANAGEMENT LLC | 4,425,784 | $67,006,370 | 32.86% |
| 5AM Venture Management, LLC | 4,408,379 | $66,742,858 | 16.63% |
| StepStone Group LP | 761,277 | $11,525,734 | 2.13% |
| TCG Crossover Management, LLC | 584,955 | $8,856,219 | 1.45% |
| Redmile Group, LLC | 1,311,572 | $19,857,200 | 0.76% |
| Nan Fung Group Holdings Ltd | 49,082 | $743,101 | 0.48% |
| Baker Brothers Advisors | 4,865,819 | $73,668,500 | 0.43% |
| Corton Capital Inc. | 18,067 | $273,534 | 0.13% |
| MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,589,700 | 0.03% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,938,308 | $44,487 | 0.01% |
| NATIXIS | 31,186 | $467,790 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,019,508 | $15,435,351 | 0.00% |
| MetLife Investment Management, LLC | 11,694 | $177,047 | 0.00% |
| Ameritas Investment Partners, Inc. | 1,767 | $26,752 | 0.00% |
| TD ASSET MANAGEMENT INC | 59,627 | $902,753 | 0.00% |
| Man Group plc | 14,466 | $219,015 | 0.00% |
| FMR LLC | 581,937 | $8,810,526 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 10,299 | $155,927 | 0.00% |
| METROPOLITAN LIFE INSURANCE CO/NY | 1,212 | $18,350 | 0.00% |
This page lists ENTRADA THERAPEUTICS INC's shareholders in Q2 2023. To view ENTRADA THERAPEUTICS INC's shareholder history, click here.